Central India Chronicle

Flower Mound, Texas, USA – August 17, 2023 – Mannatech, a global pioneer in health and wellness, proudly commemorates its 30th anniversary by celebrating three decades of innovation and advancements in the field of nutritional glycobiology. As the world finally begins to understand the importance of glycans, Mannatech is already there, leading the way in nutritional glycobiology and transforming our understanding of cellular communication and health support.

Glycoscience, once viewed as a niche field, has gained increased recognition for the pivotal role glycans play, thanks to ongoing research and analysis. This shift was further cemented when the 2022 Nobel Prize in Chemistry was awarded “for the development of click chemistry and bioorthogonal chemistry‡,” highlighting the importance of glycans, often referred to as the missing nutrient. In this thriving scientific landscape, Mannatech has been at the forefront, harnessing the power of these crucial molecules through its unique glycan technology to develop a suite of cutting-edge products.

As one of the world’s most scientifically validated supplements for cellular communication, Mannatech’s premier product, Ambrotose®, truly stands in a league of its own*. While some may associate Mannatech with high-quality aloe, a well-known source of glycans, the company’s true achievement lies in its development of the only plant-based glycan complex. This innovative complex, derived from four different plant sources, boasts an impressive composition of ten unique glycans. This varied sourcing has empowered Mannatech to elevate and refine its product offerings, providing an unmatched spectrum of health and wellness solutions that cater to diverse needs.

“Our 30-year celebration is not merely a reflection of our past, but a testament to Mannatech’s relentless commitment to revolutionizing the health and wellness industry,” said Dr. Nugent, Chief Science, and Health Officer and world-renowned expert in glycan technology. “We recognized the potential of glycans when others were still skeptical, and we are proud to lead the charge as the world begins to embrace their transformative power.”

Since its inception, Mannatech has held more than 150 patents and currently holds more than 95 active patents in major global markets, highlighting Mannatech’s dedication to scientific exploration and innovation. Their rigorous research has led to the development of a 100% plant-based complex of glycans, specifically designed to enhance cell-to-cell communication and improve immune support, cognitive health, and overall well-being*. The result of this groundbreaking research is a complete line of nutrition, skin care, and weight management products, all developed on the solid foundation of glycan technology.

To celebrate this significant milestone, CEO Al Bala, Chief Science and Health Officer Dr. Nugent, President Landen Fredrick, and other Mannatech leaders are embarking on a global celebration tour, with events scheduled in Greater China†, South Africa, the United States, Japan, Korea, and Thailand. These events will honor the achievements of the past 30 years, while also spotlighting Mannatech’s vision for the future. The celebrations will continue into 2024 with stops planned in the United Kingdom, European Union, and Australia.

“As we enter a new age of exploration and reinvestment in glycan technology, Mannatech remains committed to innovation, exploring new frontiers, and empowering individuals worldwide to achieve optimal health,” said Al Bala, CEO of Mannatech.

President Landen Fredrick adds, “Our journey over the last 30 years has been remarkable, but what excites us even more is the path that lies ahead. Our commitment to glycobiology and advanced nutritional science is unwavering, and we look forward to continuing to push the boundaries in this field.”

For more information about Mannatech and its revolutionary glycobiology research, please visit www.mannatech.com.

About Mannatech

Mannatech is a global company specializing in health and wellness, dedicated to transforming lives through its innovative products based on advanced nutritional glycobiology. With a legacy of 30 years, Mannatech continues to lead the way in revolutionizing the health and wellness industry.

Press Contact:

Michelle Luchansky
[email protected]
801.699.7802

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

†The Greater China Area mentioned above does not include the mainland China market. Mannatech operates in mainland China under a cross-border e-commerce platform that is separate from its network marketing model.

‡Press release. NobelPrize.org. Nobel Prize Outreach AB 2023. Wed. 16 Aug 2023. https://www.nobelprize.org/prizes/chemistry/2022/press-release

Nobel Prize® is a registered trademark of the Nobel Foundation.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by the use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Media Contact
Company Name: Vedette Global Media
Contact Person: Angel Tuccy
Email: Send Email
Phone: 720-257-9263
Country: United States
Website: https://vedettenews.com